Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17246468 | 0.88 | KMT2A (0.35) | MAT2AKMT2AMEN1POLBMAPT | |
| SCHEMBL21328047 | 0.86 | MAT2A (0.35) | MAT2AKMT2AMEN1NPSR1POLB | |
| SCHEMBL21339169 | 0.85 | MAT2A (0.34) | MAT2AKMT2AMEN1NPSR1POLB | |
| SCHEMBL21328046 | 0.84 | KDM4E (0.43) | MAT2AKMT2AMEN1NPSR1MAPT | |
| SCHEMBL18645883 | 0.82 | L3MBTL1 (0.36) | KMT2AMEN1POLBMAPTDUSP3 | |
| SCHEMBL15126919 | 0.81 | KMT2A (0.35) | MAT2AKMT2AMEN1NPSR1POLB | |
| SCHEMBL15335959 | 0.80 | KMT2A (0.33) | MAT2AKMT2AMEN1POLBMAPT | |
| SCHEMBL20240126 | 0.78 | MAT2A (0.43) | MAT2AKMT2AMEN1NPSR1POLB | |
| SCHEMBL15126553 | 0.78 | MAT2A (0.33) | MAT2AKMT2AMEN1POLBMAPT | |
| SCHEMBL12077685 | 0.77 | MEN1 (0.43) | MAT2AKMT2AMEN1NPSR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037348-B2 | Blue and narrow band green and red emitting metal complexes | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037348-B2 | Blue and narrow band green and red emitting metal complexes | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037348-B2 | Blue and narrow band green and red emitting metal complexes | OCIAD2, OCIAD1, ORC3 | MAT2A 4790/4885KMT2A 3784/4885MEN1 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.